Scientific Program
The latest updates by world-renowned experts in the field of diabetes
We are planning an innovative and exciting program for ATTD 2021. The full program will be available shortly.
Review the initial session topics and speakers below.
*Updated 2 July 2020
| First Name | Last Name | Country | Topic |
|---|---|---|---|
| Katharine | Barnard | UK | Patient Related Outcomes (PROs) – presentation of key instruments and how to use them (INSPIRE measures) |
| Bruce | Buckingham | USA | A pivotal trial of Omnipod Horizon™ Automated Glucose Control System |
| Fergus | Cameron | Australia | Debate: In the era of remote visits – do we still need A1c measures Stuart Weinzimer – CON Fergus Cameron – PRO |
| Antonio | Ceriello | Italy | How to manage type 2 diabetes and obesity during the COVID-19 pandemic |
| Mark | Clements | USA | What do we need to develop/improve with the technology that we are using today |
| Christophe | De Block | Belgium | NAFLD/NASH in type 1 diabetes |
| Klemen | Dovc | Slovenia | Faster acting insulin analogues in closed-loop insulin delivery |
| Francis | Doyle III | USA | Update on Artificial Pancreas engineering and clinical studies |
| Steven | Edelman | USA | Strategies for improvement of metabolic control in adults with T1D |
| Denice | Feig | Canada | DEBATE: Should all pregnant women with diabetes take metformin during pregnancy Yariv Yogev – CON Denice Feig – PRO |
| Satish | Garg | USA | Managing T1D-new-onsets and DKA through telehealth |
| Michael | Haller | USA | Using tele-education with the ECHO model to reach primary care providers in rural areas to improve the level of care for people with diabetes |
| Irl | Hirsch | USA | · Lessons learned from the COVID-19 pandemic · How should reimbursement look after the COVID-19 pandemic |
| Korey | Hood | USA | Leveraging telehealth and digital tools to optimize use of diabetes devices |
| Roman | Hovorka | UK | Use of the CamAPS FX closed-loop in the research and clinical investigation |
| Boris | Kovatchev | USA | Results of a study on Closed-Loop Control (CLC) system – Control IQ |
| Lori | Laffel | USA | · Patient preferences for automatic insulin delivery · Telemedicine for routine follow up type 1 diabetes pediatric visits |
| Robert | Lindsay | UK | Factors associated with stillbirth in women with diabetes |
| David | Maahs | USA | NIH funded study: Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study |
| Laurel | Messer | USA | Artificial pancreas device upgrades—best practices for onboarding and follow-up |
| Helen | Murphy | UK | Pregnancy outcomes of 17,375 women with diabetes: National population-based cohort study |
| Steven | Nissen | USA | Dual or triple GLP/GIPs as treatment for T2D |
| Susana | Patton | USA | Intervening on Hypoglycemia Fear in Parents of Young Children using Direct-to-Home Video-based Telehealth |
| Walter | Pories | USA | Toxic Intestinal signals as a cause of type 2 diabetes and the metabolic syndrome |
| Eric | Renard | France | Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia – the International Diabetes Closed-Loop Trial Protocol 2 |
| Michael | Riddell | Canada | Monitoring the elite athlete with type 1 |
| Francesco | Rubino | UK | An international register for new onset diabetes during COVID-19 pandemic |
| Andrea | Scaramuzza | Italy | Benefits and challenges of diabetes technology in children |
| Desmond | Schatz | USA | Lessons from the nPOD |
| Jay | Skyler | USA | · Diabetes Cardiovascular Outcome Trials – Current Status · Immunotherapy for type1 diabetes – Where are we now? |
| Amir | Tirosh | Israel | Virtual Diabetes Clinic – the Dietitian Perspective |
| Stuart | Weinzimer | USA | Debate: In the era of remote visits – do we still need A1c measures Fergus Cameron – PRO Stuart Weinzimer – CON |
| Yariv | Yogev | Israel | DEBATE: Should all pregnant women with diabetes take metformin during pregnancy CON – Yariv Yogev PRO – Denice Feig |